UA96445C2 - 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы - Google Patents

2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы

Info

Publication number
UA96445C2
UA96445C2 UAA200813950A UAA200813950A UA96445C2 UA 96445 C2 UA96445 C2 UA 96445C2 UA A200813950 A UAA200813950 A UA A200813950A UA A200813950 A UAA200813950 A UA A200813950A UA 96445 C2 UA96445 C2 UA 96445C2
Authority
UA
Ukraine
Prior art keywords
protease inhibitors
amino
substituted
benzothiazole sulfonamide
hiv protease
Prior art date
Application number
UAA200813950A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Кок Херман Августинус Де
Тим Хуго Мария Джонкерс
Пауль Джозеф Габриэль Мария Боонантс
Стефаан Джулиен Ласт
Инге Диеринк
Джудит Ева Баумистер
'Т Клоостер Гербен Алберт Элеузериус ван
Original Assignee
Тиботек Фармасьютикелз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тиботек Фармасьютикелз Лтд. filed Critical Тиботек Фармасьютикелз Лтд.
Publication of UA96445C2 publication Critical patent/UA96445C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UAA200813950A 2006-06-23 2007-06-22 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы UA96445C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06116003 2006-06-23

Publications (1)

Publication Number Publication Date
UA96445C2 true UA96445C2 (ru) 2011-11-10

Family

ID=37596252

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200813950A UA96445C2 (ru) 2006-06-23 2007-06-22 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы

Country Status (30)

Country Link
US (1) US8202887B2 (OSRAM)
EP (1) EP2035432B1 (OSRAM)
JP (1) JP5232776B2 (OSRAM)
KR (1) KR101419320B1 (OSRAM)
CN (1) CN101479275B (OSRAM)
AP (1) AP2069A (OSRAM)
AR (1) AR061619A1 (OSRAM)
AT (1) ATE544769T1 (OSRAM)
AU (1) AU2007262943B2 (OSRAM)
BR (1) BRPI0713487B1 (OSRAM)
CA (1) CA2653233C (OSRAM)
CL (1) CL2007001826A1 (OSRAM)
CY (1) CY1112971T1 (OSRAM)
DK (1) DK2035432T3 (OSRAM)
EA (1) EA016387B1 (OSRAM)
ES (1) ES2381129T3 (OSRAM)
IL (1) IL195381A (OSRAM)
JO (1) JO2841B1 (OSRAM)
MX (1) MX2009000160A (OSRAM)
MY (1) MY146805A (OSRAM)
NZ (1) NZ573286A (OSRAM)
PE (1) PE20080342A1 (OSRAM)
PL (1) PL2035432T3 (OSRAM)
PT (1) PT2035432E (OSRAM)
SI (1) SI2035432T1 (OSRAM)
TW (1) TWI415851B (OSRAM)
UA (1) UA96445C2 (OSRAM)
UY (1) UY30416A1 (OSRAM)
WO (1) WO2007147884A1 (OSRAM)
ZA (1) ZA200810350B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3090B1 (ar) 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
CN103209963A (zh) 2010-07-02 2013-07-17 吉里德科学公司 作为hiv抗病毒化合物的2-喹啉基-乙酸衍生物
AU2011274322B2 (en) 2010-07-02 2015-08-13 Gilead Sciences, Inc. Naphth- 2 -ylacetic acid derivatives to treat AIDS
US9024038B2 (en) * 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
ES2707997T3 (es) * 2011-04-21 2019-04-08 Gilead Sciences Inc Compuestos de benzotiazol y su uso farmacéutico
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
EP2788336B1 (en) 2012-04-20 2016-03-02 Gilead Sciences, Inc. Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20030735B1 (en) 2001-02-14 2012-02-29 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
AU2003262561B2 (en) * 2002-08-02 2008-10-16 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
PT1670448E (pt) * 2003-09-30 2008-02-11 Tibotec Pharm Ltd Sulfonamidas inibidoras de hcv

Also Published As

Publication number Publication date
AU2007262943A1 (en) 2007-12-27
NZ573286A (en) 2011-09-30
ATE544769T1 (de) 2012-02-15
BRPI0713487B1 (pt) 2022-07-26
EP2035432B1 (en) 2012-02-08
JO2841B1 (en) 2014-09-15
CA2653233A1 (en) 2007-12-27
CA2653233C (en) 2015-09-29
US8202887B2 (en) 2012-06-19
CL2007001826A1 (es) 2008-01-18
IL195381A (en) 2013-01-31
CY1112971T1 (el) 2016-04-13
CN101479275A (zh) 2009-07-08
PL2035432T3 (pl) 2012-07-31
KR20090024257A (ko) 2009-03-06
TWI415851B (zh) 2013-11-21
JP5232776B2 (ja) 2013-07-10
EA200970052A1 (ru) 2009-04-28
UY30416A1 (es) 2008-01-31
PT2035432E (pt) 2012-04-24
AP2069A (en) 2009-12-08
HK1125633A1 (en) 2009-08-14
CN101479275B (zh) 2012-03-07
WO2007147884A1 (en) 2007-12-27
AR061619A1 (es) 2008-09-10
SI2035432T1 (sl) 2012-06-29
JP2009541272A (ja) 2009-11-26
ES2381129T3 (es) 2012-05-23
AU2007262943B2 (en) 2012-04-12
ZA200810350B (en) 2010-05-26
EA016387B1 (ru) 2012-04-30
BRPI0713487A8 (pt) 2018-01-02
EP2035432A1 (en) 2009-03-18
US20090209583A1 (en) 2009-08-20
AP2008004679A0 (en) 2008-12-31
IL195381A0 (en) 2009-08-03
PE20080342A1 (es) 2008-04-25
DK2035432T3 (da) 2012-05-14
MY146805A (en) 2012-09-28
TW200817416A (en) 2008-04-16
MX2009000160A (es) 2009-01-23
KR101419320B1 (ko) 2014-07-14
BRPI0713487A2 (OSRAM) 2012-11-13

Similar Documents

Publication Publication Date Title
UA96445C2 (ru) 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы
NO20090628L (no) Pyridizinon derivativater
BRPI0418639B8 (pt) compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
CL2007002887A1 (es) Compuestos derivados de heterociclos, inhibidores de metaloproteinasa de la matriz (mmp); compuesto intermediario; composicion farmaceutica; kit farmaceutico; y uso en la prevencion y tratamiento en afecciones mediadas por metaloproteinasas de la mat
MX2009008925A (es) Compuestos de la formula (i) como inhibidores de proteasa de serina.
NO20090910L (no) Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister
TNSN07405A1 (en) Herbicidal compositions
DE602007006051D1 (de) Präzisionsschleifbearbeitung von werkstückoberflächen
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
UA96277C2 (en) Benzimidazole derivatives
SE0403086D0 (sv) Compounds
HN2006029142A (es) Proceso
TW200801015A (en) Substituted aminophenylsulfonamide compounds as HIV protease inhibitor
MXPA04011466A (es) Inhibidores de la proteasa de hiv de benzisoxazol sulfonamida sustituida de amplio espectro.
BRPI0414199A (pt) inibidores de entrada do vìrus hiv
CL2008002058A1 (es) Metodo para la preparacion de trifluoralquil-fenil-sulfonamidas y de sulfonamidas heterociclicas usando n-trifluoroacteilmorfolina; su metodo de preparacion y su uso.
WO2006091861A3 (en) Compositions and methods relating to cns lymphoma
DE602007005387D1 (de) Ptors
WO2008003752A8 (en) 2 -amino benzimidazole derivatives and their use as modulators of small - conductance calcium -act ivated potassium channels
TW200710091A (en) (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
EP4389221A3 (en) Pan-genotypic agents against influenza virus and methods of using the same